These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2006138)

  • 1. Conformational perturbation of interleukin-2: a strategy for the design of cytokine analogs.
    Landgraf BE; Williams DP; Murphy JR; Smith KA; Ciardelli TL
    Proteins; 1991; 9(3):207-16. PubMed ID: 2006138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analogs of interleukin-2: a point mutation that facilitates biological response.
    Chang DZ; Tasayco ML; Ciardelli TL
    Mol Pharmacol; 1995 Jan; 47(1):206-11. PubMed ID: 7838130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function relationships for the IL-2 receptor system. V. Structure-activity analysis of modified and truncated forms of the Tac receptor protein: site-specific mutagenesis of cysteine residues.
    Rusk CM; Neeper MP; Kuo LM; Kutny RM; Robb RJ
    J Immunol; 1988 Apr; 140(7):2249-59. PubMed ID: 2832473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De-novo design of complementary (antisense) peptide mini-receptor inhibitor of interleukin 18 (IL-18).
    Bhakoo A; Raynes JG; Heal JR; Keller M; Miller AD
    Mol Immunol; 2004 Nov; 41(12):1217-24. PubMed ID: 15482857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction, purification and biological activities of recombinant human interleukin-2 analogs.
    Boone T; Chazin V; Kenney W; Swanson E; Altrock B
    Dev Biol Stand; 1988; 69():157-68. PubMed ID: 3066670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of interleukin-2/p55 receptor subunit interaction by complementary peptides.
    Fassina G; Cassani G; Gnocchi P; Fornasiero MC; Isetta AM
    Arch Biochem Biophys; 1995 Apr; 318(1):37-45. PubMed ID: 7726570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding.
    Hammacher A; Ward LD; Weinstock J; Treutlein H; Yasukawa K; Simpson RJ
    Protein Sci; 1994 Dec; 3(12):2280-93. PubMed ID: 7538847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function studies of the C-terminal alpha-helix of human interleukin-2 by site-directed mutagenesis.
    Xu D; Jiang C; Shi Y; Yu J; Sun L; Fan P; Liu X
    Chin J Biotechnol; 1993; 9(4):229-34. PubMed ID: 8061231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design and characterization of a Novel IL-6 antagonist peptide.
    Yang Z; Feng J; Li Y; Hu M; Song L; Yu M; Qin W; Shen B
    Mol Immunol; 2005 May; 42(9):1015-21. PubMed ID: 15829291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.
    Schreuder H; Tardif C; Trump-Kallmeyer S; Soffientini A; Sarubbi E; Akeson A; Bowlin T; Yanofsky S; Barrett RW
    Nature; 1997 Mar; 386(6621):194-200. PubMed ID: 9062194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function relationships for the IL 2-receptor system. II. Localization of an IL 2 binding site on high and low affinity receptors.
    Kuo LM; Rusk CM; Robb RJ
    J Immunol; 1986 Sep; 137(5):1544-51. PubMed ID: 2427573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin.
    McWherter CA; Feng Y; Zurfluh LL; Klein BK; Baganoff MP; Polazzi JO; Hood WF; Paik K; Abegg AL; Grabbe ES; Shieh JJ; Donnelly AM; McKearn JP
    Biochemistry; 1999 Apr; 38(14):4564-71. PubMed ID: 10194378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A design approach to the structural analysis of interleukin-2.
    Ciardelli TL; Landgraf B; Gadski R; Strnad J; Cohen FE; Smith KA
    J Mol Recognit; 1988 Feb; 1(1):42-7. PubMed ID: 3273651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function relationships for the IL 2-receptor system. I. Localization of a receptor binding site on IL 2.
    Kuo LM; Robb RJ
    J Immunol; 1986 Sep; 137(5):1538-43. PubMed ID: 2427572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected effects of the IL-2 receptor alpha subunit on high affinity IL-2 receptor assembly and function detected with a mutant IL-2 analog.
    Kuziel WA; Ju G; Grdina TA; Greene WC
    J Immunol; 1993 Apr; 150(8 Pt 1):3357-65. PubMed ID: 8468475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 2 and its cell-surface receptor.
    Robb RJ
    Behring Inst Mitt; 1985 Aug; (77):56-67. PubMed ID: 3936474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic peptide interleukin 5 antagonists mimic CD turn recognition epitope for receptor alpha.
    Ruchala P; Varadi G; Ishino T; Scibek J; Bhattacharya M; Urbina C; Ryk DV; Uings I; Chaiken I
    Biopolymers; 2004 Apr; 73(5):556-68. PubMed ID: 15048779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and biologic properties of a human aspartic acid-126 interleukin-2 analog.
    Buchli P; Ciardelli T
    Arch Biochem Biophys; 1993 Dec; 307(2):411-5. PubMed ID: 8274030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.
    Vigers GP; Anderson LJ; Caffes P; Brandhuber BJ
    Nature; 1997 Mar; 386(6621):190-4. PubMed ID: 9062193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure function relationships for the IL 2 receptor system. III. Tac protein missing amino acids 102 to 173 (exon 4) is unable to bind IL 2: detection of spliced protein after L cell transfection.
    Neeper MP; Kuo LM; Kiefer MC; Robb RJ
    J Immunol; 1987 May; 138(10):3532-8. PubMed ID: 3033076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.